Health Technology Assessment (HTA) is a multidisciplinary science, involving a wide range of methodologies, which informs about the benefits and comparative value of interventions and provides a means by which health technologies can be assessed and prioritised against existing health care interventions This course introduces students to the wider requirements for assessing the cost-effectiveness of medical devices and diagnostics, and the role of evidence-based medicine in the decision-making process for these products. It covers pricing considerations for medical devices and diagnostics in the international arena and future applications and trends in the development of equitable access schemes for therapeutic products. Students will study new modelling strategies required which can be used to gain reimbursement for therapeutic products.

Note: This course is one of two options for the compulsory Health Economics component for programmes 5371 and 9370.